Our Science

Targeted protein degradation has emerged as a new therapeutic modality to tackle disease-causing proteins previously dismissed as too challenging to target with conventional small molecules.

With several TPD drugs now successfully advancing from research through clinical development, protein targets previously considered to be undruggable are now within reach through harnessing the cell’s natural “waste disposal system”.